Cargando…

Production of Factor VIII by Human Liver Sinusoidal Endothelial Cells Transplanted in Immunodeficient uPA Mice

Liver sinusoidal endothelial cells (LSECs) form a semi-permeable barrier between parenchymal hepatocytes and the blood. LSECs participate in liver metabolism, clearance of pathological agents, immunological responses, architectural maintenance of the liver and synthesis of growth factors and cytokin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fomin, Marina E., Zhou, Yanchen, Beyer, Ashley I., Publicover, Jean, Baron, Jody L., Muench, Marcus O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805584/ https://www.ncbi.nlm.nih.gov/pubmed/24167566 http://dx.doi.org/10.1371/journal.pone.0077255

Ejemplares similares

TEM8 functions as a receptor for uPA and mediates uPA-stimulated EGFR phosphorylation
por: Zhang, Lian-Cheng, et al.
Publicado: (2018)

Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry
por: Singer, C.F., et al.
Publicado: (2022)

The uPA/uPAR system in astrocytic wound healing
por: Yepes, Manuel
Publicado: (2022)

Construction of a Single Lentiviral Vector Containing Tetracycline-Inducible Alb-uPA for Transduction of uPA Expression in Murine Hepatocytes
por: Bai, Jiasi, et al.
Publicado: (2013)

uPA-mediated plasminogen activation is enhanced by polyphosphate
por: Whyte, Claire S., et al.
Publicado: (2020)

Suppression of uPA and uPAR Attenuates Angiogenin Mediated Angiogenesis in Endothelial and Glioblastoma Cell Lines
por: Raghu, Hari, et al.
Publicado: (2010)

Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves
por: Kochtebane, Najlah, et al.
Publicado: (2014)

Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA
por: Dreymann, Nico, et al.
Publicado: (2022)

uPA deficiency exacerbates muscular dystrophy in MDX mice
por: Suelves, Mònica, et al.
Publicado: (2007)

uPA deficiency exacerbates muscular dystrophy in MDX mice
por: Suelves, Mònica, et al.
Publicado: (2007)

COVID-19 and pneumonia: a role for the uPA/uPAR system
por: D’Alonzo, Daniele, et al.
Publicado: (2020)

Clinical significance of the uPA system in gastric cancer with peritoneal metastasis
por: Ding, Youcheng, et al.
Publicado: (2013)

uPA dependent and independent mechanisms of wound healing by C-phycocyanin
por: Madhyastha, H K, et al.
Publicado: (2008)

Human fetal liver cultures support multiple cell lineages that can engraft immunodeficient mice
por: Fomin, Marina E., et al.
Publicado: (2017)

Poised Transcription Factories Prime Silent uPA Gene Prior to Activation
por: Ferrai, Carmelo, et al.
Publicado: (2010)

The autoactivation of human single-chain urokinase-type plasminogen activator (uPA)
por: Torres-Paris, Constanza, et al.
Publicado: (2023)

Effects of ulinastatin and docetaxel on breast cancer invasion and expression of uPA, uPAR and ERK
por: Luo, Jie, et al.
Publicado: (2011)

Antibody-based PET of uPA/uPAR signaling with broad applicability for cancer imaging
por: Yang, Dongzhi, et al.
Publicado: (2016)

Prognostic significance of uPA and uPAR expression in patients with cervical cancer undergoing radiotherapy
por: Nantajit, Danupon, et al.
Publicado: (2021)

Urokinase-type plasminogen activator (uPA) regulates invasion and matrix remodelling in colorectal cancer
por: Micalet, Auxtine, et al.
Publicado: (2023)

Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation
por: Cunningham, Orla, et al.
Publicado: (2009)

Potential Role of Kringle-Integrin Interaction in Plasmin and uPA Actions (A Hypothesis)
por: Takada, Yoshikazu
Publicado: (2012)

Impact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancer
por: Märkl, Bruno, et al.
Publicado: (2019)

The uPA System Differentially Alters Fibroblast Fate and Profibrotic Ability in Skin Fibrosis
por: Zou, Ming-Li, et al.
Publicado: (2022)

Snail mediates invasion through uPA/uPAR and the MAPK signaling pathway in prostate cancer cells
por: RANDLE, DIANDRA D., et al.
Publicado: (2013)

Urokinase-type plasminogen activator (uPA) and its receptor (uPAR) promote neurorepair in the ischemic brain
por: Merino, Paola, et al.
Publicado: (2017)

TGF-β regulation of the uPA/uPAR axis modulates mesothelial-mesenchymal transition (MesoMT)
por: Logan, Ranisha, et al.
Publicado: (2021)

Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease
por: Cheng, Yang, et al.
Publicado: (2021)

The uPA/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis Progression
por: Kanno, Yosuke
Publicado: (2023)

Therapeutic Efficacy of Human Hepatocyte Transplantation in a SCID/uPA Mouse Model with Inducible Liver Disease
por: Douglas, Donna N., et al.
Publicado: (2010)

uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer
por: Qin, Wenyi, et al.
Publicado: (2008)

Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer
por: Asuthkar, Swapna, et al.
Publicado: (2013)

Tumor Budding, uPA, and PAI-1 in Colorectal Cancer: Update of a Prospective Study
por: Märkl, Bruno, et al.
Publicado: (2017)

Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma
por: He, Xiao, et al.
Publicado: (2019)

Thrombolysis Combined Therapy Using CuS@SiO(2)-PEG/uPA Nanoparticles
por: Fu, Dapeng, et al.
Publicado: (2021)

uPA‐PAI‐1 heteromerization promotes breast cancer progression by attracting tumorigenic neutrophils
por: Uhl, Bernd, et al.
Publicado: (2021)

uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy
por: Pavón, Miguel Angel, et al.
Publicado: (2016)

Construction and verification of the targeted uPA-shRNA lentiviral vector and evaluation of the transfection and silencing rate
por: WANG, WEI-SHAN, et al.
Publicado: (2014)

A Key Role for the Urokinase Plasminogen Activator (uPA) in Invasive Group A Streptococcal Infection
por: Sanderson-Smith, Martina L., et al.
Publicado: (2013)

High expression of uPA related to p38MAPK in esophageal cancer indicates poor prognosis
por: Liu, Qilong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8hrgc4k020jkmp68o4f8488c3k